A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase

<i>N</i>-acetyl-β-<i>d</i>-glucosaminidase (NAG) is an important biomarker that indicates early renal tubular damage. Its activity level in urine has been widely used for early detection and monitoring of chronic kidney disease (CKD), particularly diabetic nephropathy. Howeve...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Jie Cheng (294193) (author)
Kolejni autorzy: Taiqiang Zhao (22677110) (author), Jiasheng Yan (10287043) (author), Zhengkang Chu (22677113) (author), Yongmei Tian (560990) (author), Shi Hua (20154516) (author), Meiling Jin (3975752) (author), Peihong Xiao (1395568) (author), Jinhong Guo (613139) (author), Honghua Hu (1272258) (author)
Wydane: 2025
Hasła przedmiotowe:
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
_version_ 1849927640250580992
author Jie Cheng (294193)
author2 Taiqiang Zhao (22677110)
Jiasheng Yan (10287043)
Zhengkang Chu (22677113)
Yongmei Tian (560990)
Shi Hua (20154516)
Meiling Jin (3975752)
Peihong Xiao (1395568)
Jinhong Guo (613139)
Honghua Hu (1272258)
author2_role author
author
author
author
author
author
author
author
author
author_facet Jie Cheng (294193)
Taiqiang Zhao (22677110)
Jiasheng Yan (10287043)
Zhengkang Chu (22677113)
Yongmei Tian (560990)
Shi Hua (20154516)
Meiling Jin (3975752)
Peihong Xiao (1395568)
Jinhong Guo (613139)
Honghua Hu (1272258)
author_role author
dc.creator.none.fl_str_mv Jie Cheng (294193)
Taiqiang Zhao (22677110)
Jiasheng Yan (10287043)
Zhengkang Chu (22677113)
Yongmei Tian (560990)
Shi Hua (20154516)
Meiling Jin (3975752)
Peihong Xiao (1395568)
Jinhong Guo (613139)
Honghua Hu (1272258)
dc.date.none.fl_str_mv 2025-11-24T22:14:03Z
dc.identifier.none.fl_str_mv 10.1021/acssensors.5c02754.s002
dc.relation.none.fl_str_mv https://figshare.com/articles/media/A_Sequential_Dual-Reagent_Paper-Based_Analytical_Device_with_Structural_Release_Control_for_Point-of-Care_Detection_of_Urinary_i_N_i_Acetyl-_i_d_i_Glucosaminidase/30698765
dc.rights.none.fl_str_mv CC BY-NC 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Medicine
Cell Biology
Genetics
Biotechnology
Developmental Biology
Marine Biology
Space Science
Biological Sciences not elsewhere classified
Information Systems not elsewhere classified
utilizes structural partitioning
system uses vra
optical quantitative analysis
initiate color development
color development process
structural release control
based analytical device
linear detection range
standard clinical method
nag enzymatic reaction
chronic kidney disease
2 </ sup
kidney disease
programmed control
portable device
method provides
>< sup
early detection
detection limit
care detection
β ‑<
β -<
widely used
trigger mechanism
strong potential
sequential dual
requires portability
reagent paper
r </
programmed delay
n </
important biomarker
high risk
high reproducibility
findings highlight
correlation coefficient
complex instrumentation
clinical poct
care testing
alkaline catalyst
activity level
achieve time
>‑ glucosaminidase
>‑ acetyl
>- glucosaminidase
>- acetyl
6 %,
524 u
5 ).
dc.title.none.fl_str_mv A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
dc.type.none.fl_str_mv Dataset
Media
info:eu-repo/semantics/publishedVersion
dataset
description <i>N</i>-acetyl-β-<i>d</i>-glucosaminidase (NAG) is an important biomarker that indicates early renal tubular damage. Its activity level in urine has been widely used for early detection and monitoring of chronic kidney disease (CKD), particularly diabetic nephropathy. However, current detection methods rely on complex instrumentation, which hinders their suitability for point-of-care testing (POCT) that requires portability and user-friendliness. To address this challenge, we developed a sequential dual-reagent paper-based analytical device (SeDR-PAD) that utilizes structural partitioning and a delayed-trigger mechanism to achieve time-programmed control of the NAG enzymatic reaction and color development process. The system uses VRA-GlcNAc as the substrate to generate a chromogen under the catalysis of NAG. A portable device then releases an alkaline catalyst after a programmed delay to initiate color development, followed by optical quantitative analysis. This method provides a linear detection range of 0–200 U/L, with a detection limit of 0.524 U/L and high reproducibility (CV < 6%, <i>n</i> = 5). In a methodological comparison involving 70 clinical urine samples, the SeDR-PAD platform demonstrated strong concordance with the standard clinical method, with a correlation coefficient <i>R</i><sup>2</sup> of 0.9833. These findings highlight the strong potential of SeDR-PAD for clinical POCT of uNAG in individuals at high risk for kidney disease.
eu_rights_str_mv openAccess
id Manara_db50dc3a85b6bc4385595bffba04b59a
identifier_str_mv 10.1021/acssensors.5c02754.s002
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30698765
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY-NC 4.0
spelling A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑GlucosaminidaseJie Cheng (294193)Taiqiang Zhao (22677110)Jiasheng Yan (10287043)Zhengkang Chu (22677113)Yongmei Tian (560990)Shi Hua (20154516)Meiling Jin (3975752)Peihong Xiao (1395568)Jinhong Guo (613139)Honghua Hu (1272258)MedicineCell BiologyGeneticsBiotechnologyDevelopmental BiologyMarine BiologySpace ScienceBiological Sciences not elsewhere classifiedInformation Systems not elsewhere classifiedutilizes structural partitioningsystem uses vraoptical quantitative analysisinitiate color developmentcolor development processstructural release controlbased analytical devicelinear detection rangestandard clinical methodnag enzymatic reactionchronic kidney disease2 </ supkidney diseaseprogrammed controlportable devicemethod provides>< supearly detectiondetection limitcare detectionβ ‑<β -<widely usedtrigger mechanismstrong potentialsequential dualrequires portabilityreagent paperr </programmed delayn </important biomarkerhigh riskhigh reproducibilityfindings highlightcorrelation coefficientcomplex instrumentationclinical poctcare testingalkaline catalystactivity levelachieve time>‑ glucosaminidase>‑ acetyl>- glucosaminidase>- acetyl6 %,524 u5 ).<i>N</i>-acetyl-β-<i>d</i>-glucosaminidase (NAG) is an important biomarker that indicates early renal tubular damage. Its activity level in urine has been widely used for early detection and monitoring of chronic kidney disease (CKD), particularly diabetic nephropathy. However, current detection methods rely on complex instrumentation, which hinders their suitability for point-of-care testing (POCT) that requires portability and user-friendliness. To address this challenge, we developed a sequential dual-reagent paper-based analytical device (SeDR-PAD) that utilizes structural partitioning and a delayed-trigger mechanism to achieve time-programmed control of the NAG enzymatic reaction and color development process. The system uses VRA-GlcNAc as the substrate to generate a chromogen under the catalysis of NAG. A portable device then releases an alkaline catalyst after a programmed delay to initiate color development, followed by optical quantitative analysis. This method provides a linear detection range of 0–200 U/L, with a detection limit of 0.524 U/L and high reproducibility (CV < 6%, <i>n</i> = 5). In a methodological comparison involving 70 clinical urine samples, the SeDR-PAD platform demonstrated strong concordance with the standard clinical method, with a correlation coefficient <i>R</i><sup>2</sup> of 0.9833. These findings highlight the strong potential of SeDR-PAD for clinical POCT of uNAG in individuals at high risk for kidney disease.2025-11-24T22:14:03ZDatasetMediainfo:eu-repo/semantics/publishedVersiondataset10.1021/acssensors.5c02754.s002https://figshare.com/articles/media/A_Sequential_Dual-Reagent_Paper-Based_Analytical_Device_with_Structural_Release_Control_for_Point-of-Care_Detection_of_Urinary_i_N_i_Acetyl-_i_d_i_Glucosaminidase/30698765CC BY-NC 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/306987652025-11-24T22:14:03Z
spellingShingle A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
Jie Cheng (294193)
Medicine
Cell Biology
Genetics
Biotechnology
Developmental Biology
Marine Biology
Space Science
Biological Sciences not elsewhere classified
Information Systems not elsewhere classified
utilizes structural partitioning
system uses vra
optical quantitative analysis
initiate color development
color development process
structural release control
based analytical device
linear detection range
standard clinical method
nag enzymatic reaction
chronic kidney disease
2 </ sup
kidney disease
programmed control
portable device
method provides
>< sup
early detection
detection limit
care detection
β ‑<
β -<
widely used
trigger mechanism
strong potential
sequential dual
requires portability
reagent paper
r </
programmed delay
n </
important biomarker
high risk
high reproducibility
findings highlight
correlation coefficient
complex instrumentation
clinical poct
care testing
alkaline catalyst
activity level
achieve time
>‑ glucosaminidase
>‑ acetyl
>- glucosaminidase
>- acetyl
6 %,
524 u
5 ).
status_str publishedVersion
title A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
title_full A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
title_fullStr A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
title_full_unstemmed A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
title_short A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
title_sort A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase
topic Medicine
Cell Biology
Genetics
Biotechnology
Developmental Biology
Marine Biology
Space Science
Biological Sciences not elsewhere classified
Information Systems not elsewhere classified
utilizes structural partitioning
system uses vra
optical quantitative analysis
initiate color development
color development process
structural release control
based analytical device
linear detection range
standard clinical method
nag enzymatic reaction
chronic kidney disease
2 </ sup
kidney disease
programmed control
portable device
method provides
>< sup
early detection
detection limit
care detection
β ‑<
β -<
widely used
trigger mechanism
strong potential
sequential dual
requires portability
reagent paper
r </
programmed delay
n </
important biomarker
high risk
high reproducibility
findings highlight
correlation coefficient
complex instrumentation
clinical poct
care testing
alkaline catalyst
activity level
achieve time
>‑ glucosaminidase
>‑ acetyl
>- glucosaminidase
>- acetyl
6 %,
524 u
5 ).